ABBV-744
BD2 domain selective BET inhibitor orally efficacious in XG w/o platelet, GI tox from SBDD of BD1/2 dual inhibitors Nature, 2020, 578, 306-310 AbbVie, North Chicago, IL
Molecules of the Month - February 2020
Molecules of the Month
- LNP023
- LMB763 (nidufexor)
- ABBV-744
- AG-881
- FT-2102 (olutasidenib)
- GS-9876 (lanraplenib)
- "compound 25"
- "compound 25"-2
- WF-47-JS03
- BMS-986260
- GNF2133